News 

About IAPACEducationAdvocacyConferencesWhat's NewPublicationsJoin IAPACContact UsLinksMain Page
 

Norvir Advisory

Notice: This is an IAPAC initiative that is under the sole direction of the IAPAC Norvir Advisory Committee. Contents of the Norvir Advisory section of the IAPAC Web site are subject to the approval of the chair of the advisory committee and will reflect the recommendations of the committee members. Abbott Laboratories has no input in the content of the Norvir Advisory section of the IAPAC Web site.

Abbott Laboratories Receives U.S. FDA Approval
for Reformulated Norvir (Ritonavir) Capsule

 

About the IAPAC Norvir Advisory

The IAPAC Norvir Advisory
Frequently Asked Questions

 

Description of the Problem

 

Consequences of the Problem

 

Tolerability Issues with Norvir Liquid Formulation

 

Temperature Issues with Norvir Liquid Formulation

 

Portability

 

Adherence Issues

 

When Should Consideration Be Given to Switch to Other Antiviral Regimens?

 

Frequently Asked Questions

 

What's New on the IAPAC Norvir Advisory

Subscribe to receive email notices of site updates and additions.

 

Search the IAPAC Norvir Advisory Site

 

Share Your Experience or Ask a Question

 

Physicians' Access to Antiviral Specialists

 

How to Use the IAPAC Norvir Advisory Site